One of the first studies of its kind has found integrated PET/CT to be a highly accurate method for diagnosing coronary artery disease. The combined imaging approach can help physicians decide whether to treat these patients with revascularization or proceed conservatively, according to a study in the June issue of the Journal of Nuclear Medicine.
One of the first studies of its kind has found integrated PET/CT to be a highly accurate method for diagnosing coronary artery disease. The combined imaging approach can help physicians decide whether to treat these patients with revascularization or proceed conservatively, according to a study in the June issue of the Journal of Nuclear Medicine.
Standard imaging with coronary angiography is costly compared with alternatives such as CT angiography or intravascular coronary ultrasound. It is also invasive and carries a small risk. An average 30% of coronary angiograms yield clinically insignificant disease, and angiography cannot predict the physiologic implications of stenoses such as ischemic recurrence or vessel reocclusion after lytic therapy.
An imaging test that combines functional and anatomic capabilities could render coronary angiography unnecessary. PET/CT could be that test, according to Dr. Mehdi Namdar and colleagues at the University Hospital of Zurich in Switzerland.
Researchers enrolled 25 consecutive patients who underwent CT angiography and PET scanning on a four-slice PET/CT system. All patients had been referred for a PET myocardial perfusion scan due to a clinical history of coronary disease. They had previously undergone coronary angiography for recurrent chest pain. The investigators compared PET/CT with PET plus coronary angiography.
They found that PET/CT's high negative predictive value could help pick the right candidates for revascularization. Hybrid imaging selected 11 stenotic lesions producing perfusion defects amenable to revascularization therapy, the same number that PET plus angiography picked up. PET plus angiography and PET/CT outcomes confirmed 89 and 82 lesions for conservative treatment, respectively.
Seven arterial segments could not be evaluated by CT because of rapid vessel motion. These vessels, however, were correctly categorized by PET alone. The integration of more powerful 16- or 64-slice CT scanners into PET/CT hybrids should make up for such shortcomings and could speed clinical implementation of the technique, the researchers said.
PET/CT adds functional information on the pathophysiologic impact of a lesion, allowing accurate clinical decision making on the best therapeutic strategy. However, larger trials are necessary to obtain further confirmation, researchers said.
For more information from the Diagnostic Imaging archives:
Software transforms MSCT into coronary artery screening tool
PET reveals cardiovascular risks of obesity
Coronary CTA produces good results with better ones in the works
Chest CT Study Shows Higher Emphysema Risk from Combination of Marijuana and Cigarette Smoking
November 28th 2023People who smoke marijuana and cigarettes have 12 times the risk for centrilobular emphysema than non-smokers, according to new computed tomography (CT) research presented at the annual Radiological Society of North America (RSNA) conference.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Suggests CT-Guided Injections May Restore Sense of Smell in Patients with Long COVID
November 20th 2023Utilizing computed tomography (CT) guidance, researchers have found that performing a minimally invasive anesthetic injection into the stellate ganglia may help address parosmia due to COVID-19, according to study results that will be presented at the annual Radiological Society of North America (RSNA) conference next week.